Myriad Genetics (MYGN) Acquisitions (2011 - 2018)
Myriad Genetics (MYGN) posted quarterly Acquisitions of -$1.1 million for Q4 2018, down 100.39% quarter-over-quarter from $279.6 million in Q3 2018.
Myriad Genetics (MYGN) Acquisitions (2011 - 2018) Analysis & Trends
Myriad Genetics (MYGN) has reported Acquisitions for 4 consecutive years, with -$1.1 million the latest figure, recorded in Q4 2018.
- In Q4 2018, Acquisitions changed N/A year-over-year to -$1.1 million; the TTM figure through Dec 2020 stood at -$1.1 million (changed N/A YoY), while the FY2022 annual figure was $57.2 million, changed N/A from the prior year.
- Acquisitions retreated to -$1.1 million in Q4 2018 per MYGN's latest filing, from $279.6 million in the prior quarter.
- Across five years, Acquisitions topped out at $279.6 million in Q3 2018 and bottomed at -$1.1 million in Q4 2018.
- Historically, Acquisitions has averaged $98.9 million across 3 years, with a median of $3.1 million in 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 163.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 2.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -1.10 Mn |
| Sep 30, 2018 | 279.60 Mn |
| Dec 31, 2016 | 3.10 Mn |
| Sep 30, 2016 | 213.00 Mn |
| Jun 30, 2014 | -31,000.00 |
| Sep 30, 2011 | 799,000.00 |